CliffBio
small molecule

CORDARONE

AMIODARONE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyWyeth →See this company's full patent-cliff portfolio

Drug detail

Brand nameCORDARONE
Active ingredientAMIODARONE HYDROCHLORIDE
Strength50MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalAugust 1995
Marketing statusDISCN

More from Wyeth

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.